Physician
Pelican Family Medicine at Monkey Junction
Pelican Family Medicine at Monkey Junction was paid $428K by Medicaid between Jan 2018 and Dec 2024, across 28 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 68% of everything it billed.
33Billing provider infoPELICAN FAMILY MEDICINE AT MONKEY JUNCTION
WILMINGTON, NC 28412
WILMINGTON, NC 28412
33aNPI1588811285assigned 08/25/2008
33bProvider typeFamily Medicine Physician
28Total paid$428K
24GClaims13,852
24DCodes billed28
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in North Carolina
Rank by total paid#293 of 960
Median peer was paid$135K
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,800 | $124K | |
| 2019 | 1,554 | $71K | |
| 2020 | 671 | $30K | |
| 2021 | 1,903 | $92K | |
| 2022 | 2,080 | $83K | |
| 2023 | 1,107 | $20K | |
| 2024incomplete | 2,737 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 68% | 5,784 | 4,356 | $289K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 11% | 417 | 81 | $47K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 9.4% | 202 | 144 | $40K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.4% | 521 | 420 | $23K |
| 99199 | Unlisted special service, procedure or report | 3.2% | 4,134 | 4,091 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 119 | 40 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 49 | 32 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 84 | 27 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 28 | 24 | $1K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 117 | 40 | $1K |
| 36000 | <1% | 119 | 39 | $952.50 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 93 | 81 | $929.63 |
16 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 73 | $729.74 |
| 82947 | <1% | 530 | $603.52 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 174 | $597.81 |
| 81003 | <1% | 336 | $416.33 | |
| 90686 | <1% | 52 | $397.20 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 38 | $319.71 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 71 | $178.76 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 369 | $53.25 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 101 | $13.73 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 79 | $12.16 |
| 85018 | <1% | 12 | $8.76 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 87 | $7.22 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 115 | $4.44 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 35 | $1.00 |
| J3490 | Unclassified drugs | 0% | 96 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARMITAGE, MARK (PHYSICIAN/OWNER)
Parent organizationPELICAN FAMILY MEDICINE
| Provider | Location | Paid |
|---|---|---|
| Pelican Family Medicine, P.A. | Wilmington, NC | $1.15M |
| Pelican Family Medicine, P.A. | Hampstead, NC | $39K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.